46, avenue de la Grande Armée, 75017 Paris, FRANCE
(Address of principal executive offices)
Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.
Form 20-F ☒ Form 40-F ☐
In October 2026, Sanofi issued the press release attached hereto as Exhibit 99.1 which is incorporated herein by reference.
Exhibit Index
Exhibit No.
Description
Exhibit 99.1
Press release dated October 30, 2026: Q3 2026: double-digit growth in sales and business EPS / FY 2026: guidance upgraded
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.